Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03423706
Status:
UNKNOWN
Last Update Posted:
2019-12-17
First Post:
2018-01-16
Brief Title:
Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation
Sponsor:
First Affiliated Hospital of Harbin Medical University
Organization:
First Affiliated Hospital of Harbin Medical University
Study Overview
Official Title:
Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Building a new haploid transplanted model with high-dose CTXCD19-CARTdonor CD34 hematopoietic stem cell and Tregsto prevent graft-versus-host diseaseGVHDreduce the infectionpromote the rate of immune reconstructionseperate graft versus leukemiaGVLand GVHDthen to reduce the relapse rate after hematopoietic stem cell transplantationHSCTfor relapsed andor refractory B cell acute lymphoblastic leukemiarr-B-ALL
Detailed Description:
compare the new haplo-HSCT model with the traditional haplo-HSCT in DFSOSRFSCR and the degree of GVHDetcfor the rr B-ALL patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None